v3.26.3
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities:    
Net earnings $ 92,958 $ 108,059
Adjustments to reconcile net earnings to net cash provided by operations:    
Depreciation 8,297 8,326
Amortization 20,804 17,458
Noncurrent employee benefits (140) 45
Stock-based compensation expense 7,821 6,445
Changes in:    
Receivables 690 (22,803)
Inventories (10,508) (1,740)
Payables (3,515) 11,937
Prepaid expenses and other assets (10,059) (3,276)
Other liabilities (2,470) 4,446
Total adjustments 10,920 20,838
Net cash provided by operations 103,878 128,897
Investing activities:    
Property, plant and equipment expenditures (12,258) (9,993)
Proceeds from company owned life insurance plans 454  
Acquisitions, net of cash acquired (94,375) (184,024)
Net cash used for investing activities (106,179) (194,017)
Financing activities:    
Dividends paid (35,936) (31,791)
Proceeds from exercise of stock options 140 554
Repurchase of common stock for treasury stock (119,014)  
Net cash used for financing activities (154,810) (31,237)
Effect of foreign exchange rates on cash (977) 2,745
Decrease in cash and cash equivalents (158,088) (93,612)
Cash and cash equivalents - beginning of period 226,016 295,305
Cash and cash equivalents - end of period $ 67,928 $ 201,693